follow me on the BLUE SKY BREAKOUT board
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SHMN #9 on the most read board! https://investorshub.advfn.com/boards/most_read.aspx
Agree balamidas. We had great volume
So many great investors joined us today, expecting to run big..
SHMN #3 on the breakout board! https://investorshub.advfn.com/boards/breakoutboards.aspx
SHMN #11 on the most read board https://investorshub.advfn.com/boards/most_read.aspx
True!
Awesome:)
SHMN CEO Night added that the proposed target of pharmaceutical manufacturing company is in manufacturing and supply to third party and private label manufacturing for last 20 years. The company has more than 300+ formulation ranging from OTC to prescription to skincare to cosmeceuticals as well as veterinary segments. The company has license to manufacture, prescription, OTC and cosmeceutical products.
Agree with you CHEIF
It is heading that way imho.
Big News~SHMN acquiring Southern California based Pharmaceutical Company
Tuesday, April 27, 2021 9:45 AM
SOHM, Inc. takes a step forward in establishing its manufacturing base and network in the USA
CHINO HILLS, CA / ACCESSWIRE / April 27, 2021 / SOHM, Inc. (OTC PINK:SHMN), a generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today that the company has signed a Letter of Intent for Acquisition of a leading Southern California based Pharmaceutical company.
Mr. Baron Night, President and CEO of SOHM Inc. said, "We are very pleased to announce that after establishing the strategic manufacturing and marketing of generic Pharmaceutical, Cosmeceuticals, Personal care and Nutraceutical products range within USA, for SOHM it is a logical expansion to establish its brand name in the ever-growing generic prescription pharmaceutical and OTC market in USA. With this possible acquisition, after due diligence, SOHM would have an established distribution network in the various states"
Mr. Night added that the proposed target of pharmaceutical manufacturing company is in manufacturing and supply to third party and private label manufacturing for last 20 years. The company has more than 300+ formulation ranging from OTC to prescription to skincare to cosmeceuticals as well as veterinary segments. The company has license to manufacture, prescription, OTC and cosmeceutical products.
Besides this SOHM would also have the opportunity to manufacture in house its products in the US brands in its manufacturing facility at Southern California thus increasing the profitability. If this proposed acquisition goes through, it is in line with the Company's strategy for its growth and stability and bring synergies between the two companies.
Mr. Night went on to say that this will be one of the organic takeovers and is subject to appropriate Due diligence and it is going to be on cash basis, subject to procuring the financing needs by institutional loan or capital raise. Together with SOHM management bandwidth the all its segments will witness more applied innovation in time to come.
The company anticipates announcing its definitive agreement after proper due diligence and procuring confirmed financing methods within 2nd qtr. 2021 or early 3rd qtr.
https://www.accesswire.com/642432/SOHM-Inc-signs-a-Mutual-Letter-of-Intent-for-an-Acquisition-of-Southern-California-based-Pharmaceutical-Company
SHMN great news, 427 million volume closed at .014 AWESOME DAY
SHMN great news, 427 million volume closed at .014 AWESOME DAY
Slapping continues tomorrow possible 2-3 cents
Agree! :)
Expecting epic run tomorrow
SHMN~Amazing stock, posts NET PROFIT, CURRENT, GREAT PHARMA PRODUCTS.. IN WALMART, PUBLIX,...
SHMN 120% up, volume 330 million
$SHMN 114% up volume 325 million
SHMN 112% up volume 320 million
SHMN 112% up volume 320 million
big possibility CHIEF,
3 million dollars volume so far today, remember we had 30, 50, 60k volume a day
seems big buyers lined up
SHMN heading to .02++
SHMN~216 million volume so far great accumulation
The company has more than 300+ formulation ranging from OTC to prescription to skincare to cosmeceuticals as well as veterinary segments. The company has license to manufacture, prescription, OTC and cosmeceutical products.
Besides this SOHM would also have the opportunity to manufacture in house its products in the US brands in its manufacturing facility at Southern California thus increasing the profitability. If this proposed acquisition goes through, it is in line with the Company's strategy for its growth and stability and bring synergies between the two companies.
Agree news is very big
possible 5, 10, 20 cents in coming days
probably will be very thin
SHMN~ 1 CENT~ under is history imho..
going that way huge news!
SHMN HUGE NEWS OUT~ SOHM, Inc., signs a Mutual Letter of Intent for an Acquisition of Southern California based Pharmaceutical Company
Tuesday, April 27, 2021 9:45 AM
Share this article now
Topic: Mergers and Acquisitions
SOHM, Inc. takes a step forward in establishing its manufacturing base and network in the USA
CHINO HILLS, CA / ACCESSWIRE / April 27, 2021 / SOHM, Inc. (OTC PINK:SHMN), a generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today that the company has signed a Letter of Intent for Acquisition of a leading Southern California based Pharmaceutical company.
Mr. Baron Night, President and CEO of SOHM Inc. said, "We are very pleased to announce that after establishing the strategic manufacturing and marketing of generic Pharmaceutical, Cosmeceuticals, Personal care and Nutraceutical products range within USA, for SOHM it is a logical expansion to establish its brand name in the ever-growing generic prescription pharmaceutical and OTC market in USA. With this possible acquisition, after due diligence, SOHM would have an established distribution network in the various states"
Mr. Night added that the proposed target of pharmaceutical manufacturing company is in manufacturing and supply to third party and private label manufacturing for last 20 years. The company has more than 300+ formulation ranging from OTC to prescription to skincare to cosmeceuticals as well as veterinary segments. The company has license to manufacture, prescription, OTC and cosmeceutical products.
Besides this SOHM would also have the opportunity to manufacture in house its products in the US brands in its manufacturing facility at Southern California thus increasing the profitability. If this proposed acquisition goes through, it is in line with the Company's strategy for its growth and stability and bring synergies between the two companies.
Mr. Night went on to say that this will be one of the organic takeovers and is subject to appropriate Due diligence and it is going to be on cash basis, subject to procuring the financing needs by institutional loan or capital raise. Together with SOHM management bandwidth the all its segments will witness more applied innovation in time to come.
The company anticipates announcing its definitive agreement after proper due diligence and procuring confirmed financing methods within 2nd qtr. 2021 or early 3rd qtr.
About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a vision "Globalè Prospèro" that tries to build continuous growth. SOHM manufacturing and marketing targets the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing alliances in India as well as has strategic alliances with US manufacturing facilities. Although SOHM's generic pharmaceuticals are exported globally and were introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.
To know more about SOHM, Inc., visit www.SOHM.com
Safe Harbor Statement:
This news release contains "forward-looking statements", which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs, and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations, or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report for the most recent fiscal year, our quarterly reports uploaded from time-to-time on OTCMarkets.com.
For more information, please contact:
SOHM, Inc.
714-522-6700
https://www.accesswire.com/642432/SOHM-Inc-signs-a-Mutual-Letter-of-Intent-for-an-Acquisition-of-Southern-California-based-Pharmaceutical-Company
Agree, no dilution, low float great news
I believe multi-pennies coming
SHMN HUGE NEWS OUT~ SOHM, Inc., signs a Mutual Letter of Intent for an Acquisition of Southern California based Pharmaceutical Company
Tuesday, April 27, 2021 9:45 AM
Share this article now
Topic: Mergers and Acquisitions
SOHM, Inc. takes a step forward in establishing its manufacturing base and network in the USA
CHINO HILLS, CA / ACCESSWIRE / April 27, 2021 / SOHM, Inc. (OTC PINK:SHMN), a generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today that the company has signed a Letter of Intent for Acquisition of a leading Southern California based Pharmaceutical company.
Mr. Baron Night, President and CEO of SOHM Inc. said, "We are very pleased to announce that after establishing the strategic manufacturing and marketing of generic Pharmaceutical, Cosmeceuticals, Personal care and Nutraceutical products range within USA, for SOHM it is a logical expansion to establish its brand name in the ever-growing generic prescription pharmaceutical and OTC market in USA. With this possible acquisition, after due diligence, SOHM would have an established distribution network in the various states"
Mr. Night added that the proposed target of pharmaceutical manufacturing company is in manufacturing and supply to third party and private label manufacturing for last 20 years. The company has more than 300+ formulation ranging from OTC to prescription to skincare to cosmeceuticals as well as veterinary segments. The company has license to manufacture, prescription, OTC and cosmeceutical products.
Besides this SOHM would also have the opportunity to manufacture in house its products in the US brands in its manufacturing facility at Southern California thus increasing the profitability. If this proposed acquisition goes through, it is in line with the Company's strategy for its growth and stability and bring synergies between the two companies.
Mr. Night went on to say that this will be one of the organic takeovers and is subject to appropriate Due diligence and it is going to be on cash basis, subject to procuring the financing needs by institutional loan or capital raise. Together with SOHM management bandwidth the all its segments will witness more applied innovation in time to come.
The company anticipates announcing its definitive agreement after proper due diligence and procuring confirmed financing methods within 2nd qtr. 2021 or early 3rd qtr.
About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a vision "Globalè Prospèro" that tries to build continuous growth. SOHM manufacturing and marketing targets the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing alliances in India as well as has strategic alliances with US manufacturing facilities. Although SOHM's generic pharmaceuticals are exported globally and were introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.
To know more about SOHM, Inc., visit www.SOHM.com
Safe Harbor Statement:
This news release contains "forward-looking statements", which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs, and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations, or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report for the most recent fiscal year, our quarterly reports uploaded from time-to-time on OTCMarkets.com.
For more information, please contact:
SOHM, Inc.
714-522-6700
https://www.accesswire.com/642432/SOHM-Inc-signs-a-Mutual-Letter-of-Intent-for-an-Acquisition-of-Southern-California-based-Pharmaceutical-Company
seems under 1 cent will be history
Fight Aging!
04/26/2021 posted in Blog
Share1
Shopping for anti-aging products is often hit-or-miss. Every person has different skin care needs and finding all-in-one product has become impossible. Dermatologist suggests few tips that can help fight aging skin:
The Sun: Protect your skin from the sun as much as possible. If you are planning to go on a vacation or spending the day at the beach, sun protection is essential. Try to shop for a sunscreen that is broad-spectrum, SPF 30 (or higher), and water-resistant. Be sure to reapply your sunscreen every two hours when you are outside on a bright sunny day.
Cleanser: Using heavy face masks and face scrubbing can irritate the skin. Irritating your skin can accelerate skin to age faster. Using a gentle face cleanser will help remove dirt without irritating your skin.
Moisturizer: Always give moisturizers a few weeks to show results. During this process start looking for major symptoms on your skin. Later look at the signs that bother you. Focusing on specific issues will help to buy the right product. Always remember, your skin needs care during the daytime as well as at night.
Educate: Information is available everywhere. All you have to do is look at the right place for the right information. If you are serious about your skin, invest time and do your homework. Always read labels before buying. Study your skin and your skin type. This will help down narrow down your perfect product that is right for your skin.
Myth- Best skin care products are always expensive.
Fact – Effective anti-aging products come in all price range.
Last but not least – It is human nature to believe that products advertised as “Clinically Proven” have been tested and are good for all skin types. “Clinically Proven” means that the product was provided to customers on trial. It does not mean the product underwent clinical trials and received approval from the U.S. Food and Drug Administration (FDA)
Published 26 APRIL 2021 Written by S. Jacob
References
Castanet J, Ortonne JP. “Pigmentary changes in aged and photoaged skin.” Arch Dermatol. 1997 Oct;133(10):1296-9.
American Academy of Dermatology Association “11 ways to reduce premature skin aging.”
https://www.aad.org/public/everyday-care/skin-care-secrets/anti-aging/reduce-premature-aging-skin
Disclaimers
All the information on this blog is published in good faith and for general information purpose only. We do not make any warranties about the completeness, reliability, and accuracy of this information. Any action you take upon the information you find on this blog is strictly at your own risk. We will not be liable for any losses and/or damages in connection with the use of this information on our blog.
From our website, you can visit other websites by following hyperlinks to such external sites. While we strive to provide only quality links to useful and ethical websites, we have no control over the content and nature of these sites. These links to other websites do not imply a recommendation for all the content found on these sites. Site owners and content may change without notice and may occur before we have the opportunity to remove a link which may have gone ‘bad’.
Please be also aware that when you leave our website, other sites may have different privacy policies and terms that are beyond our control. Please be sure to check the Privacy Policies of these sites as well as their “Terms of Service” before engaging in anybusiness or uploading any information.
https://www.sohm.com/2021/04/26/fight-aging/#.YIdpNKVKmJg.twitter
Great DD ConcreteCowboy7
agree!